Stephen F. Betz, Chief Scientific Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 6,252 shares at $19.59 ($122K) on 2023-02-01, disclosed to the SEC on 2023-02-03.
Open-market sale of $122k CRNX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.59 | 3,126 | $61K | 50.0% |
| 2 | $19.59 | 3,126 | $61K | 50.0% |
| Total | $19.59 avg | 6,252 | $122K | 100% |
| Filing → |
| CRNX | SELL | 2025-03-21 | $385K | — | Filing → |
| CRNX | SELL | 2024-09-12 | $107K | — | Filing → |
| CRNX | SELL | 2024-08-28 | $160K | — | Filing → |